Origin (OBK) Q2 2025 Earnings Transcript

Origin Bancorp reported improved profitability metrics, including approximately $34 million of annual pretax pre-provision earnings enhancement actions, a 17 bps NIM increase to 3.61%, and 11 straight quarters of tangible book value growth to $33.33. Management raised 4Q25 NIM guidance to 3.70% and FY25 NIM guidance to 3.55%, announced a new $50 million buyback, and said a 20% Argent Financial stake should add about $6 million of annual income starting in 2026, though deposit declines and softer loan growth remain headwinds.

Analysis

OBK is turning into a cleaner earnings comp than the headline bank metrics imply. The market should focus on the combination of higher recurring margin, lower operating intensity, and a one-time asset reclassification that converts a capital allocation story into an income story; that mix can drive multiple expansion even if core loan growth stays subdued. The big second-order effect is that management is effectively choosing balance-sheet efficiency over asset growth, which should support ROA/ROTCE in the near term but caps top-line beta if the economy re-accelerates.

The key risk is that the bank is leaning into a self-imposed growth ceiling right as its operating leverage is improving. Staying under the asset threshold defers a meaningful regulatory cost, but it also means the bank may forgo the optics of faster balance-sheet growth while competitors with less disciplined funding profiles chase volume. That creates a setup where near-term earnings quality improves, but the stock may not rerate unless investors believe the redeployed capital and banker lift-outs can re-accelerate growth in 2026.

Credit looks benign now, but the more important read-through is that utilization/paydown behavior is a macro tell: customers are acting cautiously and using cash rather than debt. If rates fall and project confidence returns, OBK should get a double benefit from loan growth and stable funding costs; if not, the current margin upside can still hold, but the growth narrative stalls. The asymmetric catalyst is the Q3 Argent write-up and the 2026 income step-up, which could make next year look materially better than sell-side models currently reflect.

Consensus seems to be missing that this is less a traditional bank growth story and more a repositioning trade: earnings power is rising faster than reported revenue because management is stripping out inefficiency and monetizing a minority investment. The stock can work even without a dramatic macro tailwind if execution stays disciplined and buybacks continue below intrinsic value. The contrarian concern is that the easiest gains have already been harvested, so incremental upside now depends on proving that the new expense base and banker recruitment can sustain mid-single-digit to high-single-digit organic growth once the asset cap pressure eases.

Key Decisions for Investors

• Long OBK outright for 3-6 months: prefer buying on post-earnings consolidation rather than strength; thesis is a re-rating driven by NIM upgrade, Argent income conversion, and buyback support, with downside cushioned by tangible book growth.
• Buy OBK Jan-2026 calls or call spreads: target a move toward a higher ROTCE multiple as the market capitalizes the 2026 Argent income step-up; risk/reward improves if shares remain below tangible book plus a modest premium.
• Pair trade: long OBK / short a larger regional bank with weaker margin expansion and less capital return flexibility over the next 1-2 quarters; OBK has a clearer self-help catalyst stack while many peers are still waiting on volume recovery.
• If OBK rallies on the Argent write-up, take partial profits and keep a core position only; the near-term valuation lift may price in before the 2026 recurring income benefit is fully visible.
• Avoid chasing the stock if deposit outflows re-accelerate or loan utilization remains weak for another quarter; that would confirm the current margin story is outrunning underlying balance-sheet demand.